Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes

Breast Cancer Research and Treatment

Volumn 125, Issue 3, 2011, Pages 715-727

  Zeng, Xiao Hua ^a,b   Ou, Zhou Luo ^a   Yu, Ke Da ^a   Feng, Lan Yun ^a   Yin, Wen Jing ^a   Li, Jing ^a   Shen, Zhen Zhou ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Atypical chemokine binders; Breast cancer; CCX CKR; D6; DARC; Prognosis

Indexed keywords

AROMATASE INHIBITOR; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR D6; CYCLOPHOSPHAMIDE; DOCETAXEL; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; DUFFY BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; LYMPHOCYTE ANTIGEN RECEPTOR; METHOTREXATE; PACLITAXEL; PROGESTERONE RECEPTOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RELAPSE; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOKINES; DUFFY BLOOD-GROUP SYSTEM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MENOPAUSE; MIDDLE AGED; RECEPTORS, CCR; RECEPTORS, CCR10; RECEPTORS, CELL SURFACE; TREATMENT OUTCOME;

EID: 79151476277     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0875-2     Document Type: Article

References (61)

1. A Muller B Homey H Soto N Ge D Catron ME Buchanan T McClanahan E Murphy W Yuan SN Wagner, et al. 2001 Involvement of chemokine receptors in breast cancer metastasis Nature 410 6824 50 56 1:CAS:528:DC%2BD3MXhvVSgu74%3D 10.1038/35065016 11242036 (Pubitemid 32225831)
2. A Ben-Baruch 2008 Organ selectivity in metastasis: regulation by chemokines and their receptors Clin Exp Metastasis 25 4 345 356 1:CAS:528:DC%2BD1cXptVSqu7c%3D 10.1007/s10585-007-9097-3 17891505 (Pubitemid 351748979)
3. S Ali G Lazennec 2007 Chemokines: novel targets for breast cancer metastasis Cancer Metastasis Rev 26 3-4 401 420 1:CAS:528:DC%2BD2sXht1yktLbJ 10.1007/s10555-007-9073-z 17717637 (Pubitemid 350115103)
4. JM Wang O Chertov P Proost JJ Li P Menton L Xu S Sozzani A Mantovani W Gong V Schirrmacher, et al. 1998 Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NF-kappaB activation Int J Cancer 75 6 900 907 1:CAS:528:DyaK1cXhsFGrtLk%3D 10.1002/(SICI)1097-0215(19980316)75:6<900::AID- IJC13>3.0.CO;2-6 9506536 (Pubitemid 28134116)
5. A Ben-Baruch 2006 The multifaceted roles of chemokines in malignancy Cancer Metastasis Rev 25 3 357 371 1:CAS:528:DC%2BD28Xht1yktb3J 10.1007/s10555-006-9003-5 17016763 (Pubitemid 44922355)
6. H Kulbe NR Levinson F Balkwill JL Wilson 2004 The chemokine network in cancer-much more than directing cell movement Int J Dev Biol 48 5-6 489 496 1:CAS:528:DC%2BD2cXhtVentLfK 10.1387/ijdb.041814hk 15349823 (Pubitemid 39360399)
7. SC Peiper ZX Wang K Neote AW Martin HJ Showell MJ Conklyn K Ogborne TJ Hadley ZH Lu J Hesselgesser, et al. 1995 The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor J Exp Med 181 4 1311 1317 1:CAS:528:DyaK2MXkslWntro%3D 10.1084/jem.181.4.1311 7699323
8. RJ Nibbs SM Wylie IB Pragnell GJ Graham 1997 Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5 J Biol Chem 272 19 12495 12504 1:CAS:528:DyaK2sXjtFyks7k%3D 10.1074/jbc.272.19.12495 9139699 (Pubitemid 27203340)
9. J Gosling DJ Dairaghi Y Wang M Hanley D Talbot Z Miao TJ Schall 2000 Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK J Immunol 164 6 2851 2856 1:CAS:528:DC%2BD3cXhvVeltbw%3D 10706668
10. M Kashiwazaki T Tanaka H Kanda Y Ebisuno D Izawa N Fukuma N Akimitsu K Sekimizu M Monden M Miyasaka 2003 A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions Int Immunol 15 10 1219 1227 1:CAS:528:DC%2BD3sXosFOiu70%3D 10.1093/intimm/dxg121 13679391 (Pubitemid 37220495)
11. AM Fra M Locati K Otero M Sironi P Signorelli ML Massardi M Gobbi A Vecchi S Sozzani A Mantovani 2003 Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6 J Immunol 170 5 2279 2282 1:CAS:528:DC%2BD3sXht12hsL0%3D 12594248
12. M Locati YM Torre E Galliera R Bonecchi H Bodduluri G Vago A Vecchi A Mantovani 2005 Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines Cytokine Growth Factor Rev 16 6 679 686 1:CAS:528:DC%2BD2MXhtFKmsr7E 10.1016/j.cytogfr.2005.05.003 15996892 (Pubitemid 41505523)
13. GJ Graham CS McKimmie 2006 Chemokine scavenging by D6: a movable feast? Trends Immunol 27 8 381 386 1:CAS:528:DC%2BD28XntV2ns7Y%3D 10.1016/j.it.2006.06. 006 16814608 (Pubitemid 44038664)
14. CA Hansell CV Simpson RJ Nibbs 2006 Chemokine sequestration by atypical chemokine receptors Biochem Soc Trans 34 Pt 6 1009 1013 1:CAS:528: DC%2BD28XhtFKgtLjL 17073739
15. G Haraldsen A Rot 2006 Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines Eur J Immunol 36 7 1659 1661 1:CAS:528:DC%2BD28XnslOnurw%3D 10.1002/eji.200636327 16791884 (Pubitemid 44089032)
16. I Comerford W Litchfield Y Harata-Lee RJ Nibbs SR McColl 2007 Regulation of chemotactic networks by 'atypical' receptors Bioessays 29 3 237 247 1:CAS:528:DC%2BD2sXjs1Gmtr8%3D 10.1002/bies.20537 17295321 (Pubitemid 46384163)
17. R Horuk ZX Wang SC Peiper J Hesselgesser 1994 Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line J Biol Chem 269 26 17730 17733 1:CAS:528: DyaK2cXkvVSks78%3D 7517400
18. I Desbaillets AC Diserens N Tribolet MF Hamou EG Van Meir 1997 Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis J Exp Med 186 8 1201 1212 1:CAS:528:DyaK2sXmvVeisrw%3D 10.1084/jem.186.8.1201 9334359 (Pubitemid 27469015)
19. T Tang JD Owen J Du CL Walker A Richmond 1998 Molecular cloning and characterization of a mouse gene with homology to the Duffy-antigen receptor for chemokines DNA Seq 9 3 129 143 1:CAS:528:DC%2BD3cXislSrurc%3D 10520743
20. AB Lentsch 2002 The Duffy antigen/receptor for chemokines (DARC) and prostate cancer: a role as clear as black and white? FASEB J 16 9 1093 1095 1:CAS:528:DC%2BD38XltlKhs7g%3D 10.1096/fj.02-0066hyp 12087071 (Pubitemid 34753516)
21. H Shen R Schuster KF Stringer SE Waltz AB Lentsch 2006 The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth FASEB J 20 1 59 64 1:CAS:528:DC%2BD28XislSmsg%3D%3D 10.1096/fj.05-4764com 16394268 (Pubitemid 43100476)
22. S Bandyopadhyay R Zhan A Chaudhuri M Watabe SK Pai S Hirota S Hosobe T Tsukada K Miura Y Takano, et al. 2006 Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression Nat Med 12 8 933 938 1:CAS:528:DC%2BD28Xnsl2iur0%3D 10.1038/nm1444 16862154 (Pubitemid 44175145)
23. CL Addison JA Belperio MD Burdick RM Strieter 2004 Overexpression of the Duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis BMC Cancer 4 28 10.1186/1471-2407-4-28 15214968 (Pubitemid 40180304)
24. LW Horton Y Yu S Zaja-Milatovic RM Strieter A Richmond 2007 Opposing roles of murine Duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth Cancer Res 67 20 9791 9799 1:CAS:528:DC%2BD2sXhtFOnsbzL 10.1158/0008-5472.CAN-07-0246 17942909 (Pubitemid 47621226)
25. RJ Nibbs E Kriehuber PD Ponath D Parent S Qin JD Campbell A Henderson D Kerjaschki D Maurer GJ Graham, et al. 2001 The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors Am J Pathol 158 3 867 877 1:CAS:528:DC%2BD3MXitlOnurk%3D 11238036
26. M Daibata Y Matsuo H Machida T Taguchi Y Ohtsuki H Taguchi 2004 Differential gene-expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56+ T-cell large granular lymphocyte leukemia Int J Cancer 108 6 845 851 1:CAS:528:DC%2BD2cXht1Cit7Y%3D 10.1002/ijc.11647 14712486 (Pubitemid 38112612)
27. Y Martinez de la Torre C Buracchi EM Borroni J Dupor R Bonecchi M Nebuloni F Pasqualini A Doni E Lauri C Agostinis, et al. 2007 Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 Proc Natl Acad Sci USA 104 7 2319 2324 1:CAS:528: DC%2BD2sXisVSitr8%3D 10.1073/pnas.0607514104 17283337 (Pubitemid 46391395)
28. EM Borroni C Buracchi YM de la Torre E Galliera A Vecchi R Bonecchi A Mantovani M Locati 2006 The chemoattractant decoy receptor D6 as a negative regulator of inflammatory responses Biochem Soc Trans 34 Pt 6 1014 1017 1:CAS:528:DC%2BD28XhtFKgtLjE 17073740
29. RJ Nibbs DS Gilchrist V King A Ferra S Forrow KD Hunter GJ Graham 2007 The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors J Clin Investig 117 7 1884 1892 1:CAS:528: DC%2BD2sXnvVansrg%3D 10.1172/JCI30068 17607362 (Pubitemid 47036322)
30. Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C, Arena V, Fantini M, Roncalli M, Malesci A et al (2009) The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut 59:197-206
31. J Wang ZL Ou YF Hou JM Luo ZZ Shen J Ding ZM Shao 2006 Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential Oncogene 25 54 7201 7211 1:CAS:528:DC%2BD28Xht1SrtbrF 10.1038/sj.onc.1209703 16785997 (Pubitemid 44764189)
32. FY Wu ZL Ou LY Feng JM Luo LP Wang ZZ Shen ZM Shao 2008 Chemokine decoy receptor d6 plays a negative role in human breast cancer Mol Cancer Res 6 8 1276 1288 1:CAS:528:DC%2BD1cXpvVarurc%3D 10.1158/1541-7786.MCR-07-2108 18708360
33. LY Feng ZL Ou FY Wu ZZ Shen ZM Shao 2009 Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival Clin Cancer Res 15 9 2962 2970 1:CAS:528:DC%2BD1MXltFOrt7Y%3D 10.1158/1078-0432.CCR-08-2495 19383822
34. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2005 Reporting recommendations for tumor marker prognostic studies J Clin Oncol 23 36 9067 9072 10.1200/JCO.2004.01.0454 16172462
35. DF Hayes S Ethier ME Lippman 2006 New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK Breast Cancer Res Treat 100 2 237 238 10.1007/s10549-006-9253-5 16773436 (Pubitemid 44631926)
36. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2006 REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 2 229 235 10.1007/s10549-006-9242-8 16932852 (Pubitemid 44631925)
37. KD Yu GH Di J Wu JS Lu KW Shen ZZ Shen ZM Shao 2007 Development and trends of surgical modalities for breast cancer in China: a review of 16-year data Ann Surg Oncol 14 9 2502 2509 10.1245/s10434-007-9436-2 17564750 (Pubitemid 47389574)
38. I Jatoi A Tsimelzon H Weiss GM Clark SG Hilsenbeck 2005 Hazard rates of recurrence following diagnosis of primary breast cancer Breast Cancer Res Treat 89 2 173 178 10.1007/s10549-004-1722-0 15692760 (Pubitemid 40249051)
39. SM Hsu L Raine H Fanger 1981 Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J Histochem Cytochem 29 4 577 580 1:STN:280: DyaL3M3ktVKrug%3D%3D 6166661
40. W Remmele HE Stegner 1987 Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 3 138 140 1:STN:280: DyaL2s3ovFGhsQ%3D%3D 3303008
41. WJ Yin JS Lu GH Di YP Lin LH Zhou GY Liu J Wu KW Shen QX Han ZZ Shen, et al. 2009 Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients Breast Cancer Res Treat 115 2 325 333 10.1007/s10549-008-0096-0 18563552
42. HC Li DC Cao Y Liu YF Hou J Wu JS Lu GH Di G Liu FM Li ZL Ou, et al. 2004 Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma Breast Cancer Res Treat 88 1 75 85 1:CAS:528:DC%2BD2cXpsF2msbk%3D 10.1007/s10549-004-1200-8 15538048 (Pubitemid 39524447)
43. C Chavey F Bibeau S Gourgou-Bourgade S Burlinchon F Boissiere D Laune S Roques G Lazennec 2007 Oestrogen receptor negative breast cancers exhibit high cytokine content Breast Cancer Res 9 1 R15 10.1186/bcr1648 17261184 (Pubitemid 350215146)
44. G Luboshits S Shina O Kaplan S Engelberg D Nass B Lifshitz-Mercer S Chaitchik I Keydar A Ben-Baruch 1999 Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma Cancer Res 59 18 4681 4687 1:CAS:528: DyaK1MXmtVKkt7w%3D 10493525
45. N Yaal-Hahoshen S Shina L Leider-Trejo I Barnea EL Shabtai E Azenshtein I Greenberg I Keydar A Ben-Baruch 2006 The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients Clin Cancer Res 12 15 4474 4480 1:CAS:528:DC%2BD28XnvVGlu7o%3D 10.1158/1078-0432.CCR-06-0074 16899591 (Pubitemid 44297794)
46. P Fanti M Nazareth R Bucelli M Mineo K Gibbs M Kumin K Grzybek J Hoeltke L Raiber K Poppenberg, et al. 2003 Estrogen decreases chemokine levels in murine mammary tissue: implications for the regulatory role of MIP-1 alpha and MCP-1/JE in mammary tumor formation Endocrine 22 2 161 168 1:CAS:528: DC%2BD3sXpvV2ns7s%3D 10.1385/ENDO:22:2:161 14665721 (Pubitemid 38019124)
47. T Ueno M Toi H Saji M Muta H Bando K Kuroi M Koike H Inadera K Matsushima 2000 Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin Cancer Res 6 8 3282 3289 1:CAS:528:DC%2BD3cXmsVOmt7c%3D 10955814
48. M Ohta Y Kitadai S Tanaka M Yoshihara W Yasui N Mukaida K Haruma K Chayama 2002 Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas Int J Cancer 102 3 220 224 1:CAS:528:DC%2BD38Xotlait7k%3D 10.1002/ijc.10705 12397639 (Pubitemid 35222287)
49. Y Lu Z Cai G Xiao Y Liu ET Keller Z Yao J Zhang 2007 CCR2 expression correlates with prostate cancer progression J Cell Biochem 101 3 676 685 1:CAS:528:DC%2BD2sXltFCqsr8%3D 10.1002/jcb.21220 17216598 (Pubitemid 46698852)
50. P Monti BE Leone F Marchesi G Balzano A Zerbi F Scaltrini C Pasquali G Calori F Pessi C Sperti, et al. 2003 The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity Cancer Res 63 21 7451 7461 1:CAS:528:DC%2BD3sXovVGltbw%3D 14612545
51. FO Ferreira FL Ribeiro AC Batista CR Leles R de Cassia Goncalves Alencar TA Silva 2008 Association of CCL2 with lymph node metastasis and macrophage infiltration in oral cavity and lip squamous cell carcinoma Tumour Biol 29 2 114 121 1:CAS:528:DC%2BD1cXosl2mtr8%3D 10.1159/000137669 18525219
52. A Lebrecht C Grimm T Lantzsch E Ludwig L Hefler E Ulbrich H Koelbl 2004 Monocyte chemoattractant protein-1 serum levels in patients with breast cancer Tumour Biol 25 1-2 14 17 1:CAS:528:DC%2BD2cXksl2nsr4%3D 10.1159/000077718 15192307 (Pubitemid 38822766)
53. JD Holland M Kochetkova C Akekawatchai M Dottore A Lopez SR McColl 2006 Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells Cancer Res 66 8 4117 4124 1:CAS:528: DC%2BD28XjsFSltrY%3D 10.1158/0008-5472.CAN-05-1631 16618732
54. B Nakata S Fukunaga E Noda R Amano N Yamada K Hirakawa 2008 Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer Oncology 74 1-2 69 75 1:CAS:528:DC%2BD1cXnvFSjsLw%3D 10.1159/000139126 18544997 (Pubitemid 351915012)
55. J Wang RR Seethala Q Zhang W Gooding C van Waes H Hasegawa RL Ferris 2008 Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy J Natl Cancer Inst 100 7 502 512 1:CAS:528:DC%2BD1cXktlOktL0%3D 10.1093/jnci/djn059 18364504
56. HE Wiley EB Gonzalez W Maki MT Wu ST Hwang 2001 Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma J Natl Cancer Inst 93 21 1638 1643 1:CAS:528:DC%2BD3MXptVegt7c%3D 10.1093/jnci/93.21.1638 11698568
57. I Bieche C Chavey C Andrieu M Busson S Vacher L Le Corre JM Guinebretiere S Burlinchon R Lidereau G Lazennec 2007 CXC chemokines located in the 4q21 region are up-regulated in breast cancer Endocr Relat Cancer 14 4 1039 1052 1:CAS:528:DC%2BD1cXivFagur8%3D 10.1677/erc.1.01301 18045955 (Pubitemid 351252435)
58. KC Smith AC Bateman HM Fussell WM Howell 2004 Cytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 31 4 167 173 1:CAS:528:DC%2BD2cXnsFSjsr8%3D 10.1111/j.1365-2370.2004.00462.x 15265021 (Pubitemid 39049861)
59. IH Benoy R Salgado P Van Dam K Geboers E Van Marck S Scharpe PB Vermeulen LY Dirix 2004 Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival Clin Cancer Res 10 21 7157 7162 1:CAS:528:DC%2BD2cXpsVKltLk%3D 10.1158/1078-0432.CCR- 04-0812 15534087 (Pubitemid 39487700)
60. I Bieche F Lerebours S Tozlu M Espie M Marty R Lidereau 2004 Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature Clin Cancer Res 10 20 6789 6795 1:CAS:528: DC%2BD2cXpslGltL4%3D 10.1158/1078-0432.CCR-04-0306 15501955 (Pubitemid 39383027)
61. Y Niwa H Akamatsu H Niwa H Sumi Y Ozaki A Abe 2001 Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer Clin Cancer Res 7 2 285 289 1:CAS:528:DC%2BD3MXhvFKnsLs%3D 11234881